Clinical Trials
8 trialsNCT04154956 2026-05-18
CARMEN-LC03
Sanofi
Phase 3 Terminated
NCT04394624 2025-06-06
CARMEN-LC04
Sanofi
Phase 2 Terminated
NCT02443337 2020-12-09
A Study of LY3023414 and Necitumumab in Squamous Lung Cancer
Eli Lilly and Company
Phase 2 Terminated
NCT02228421 2020-03-11
Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients
PeriPharm
Terminated
NCT03477474 2019-10-10
GEODE
Guardant Health, Inc.
Terminated
NCT01752023 2018-10-17
NA_00067809
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT01471964 2018-05-17
Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer
Fox Chase Cancer Center
Phase 1/2 Terminated
NCT02299765 2017-11-27
Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC
Sichuan University
Phase 4 Terminated